We are live on
!
Find out more
ZEAL
Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL
Delisted
ZEAL was delisted on the 29th of September, 2022.
10 hedge funds and large institutions have $12.5M invested in Zealand Pharma A/S American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
17% less funds holding
Funds holding: 12 → 10 (-2)
26% less capital invested
Capital invested by funds: $16.8M → $12.5M (-$4.29M)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Holders
10
Holders Change
-2
Holders Change %
-16.67%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$1.19M |
| 2 |
AIC
AWM Investment Company
New York
|
+$586K |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.5M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$221K |
| 3 |
Morgan Stanley
New York
|
-$53.7K |
| 4 |
BlackRock
New York
|
-$21.1K |
| 5 |
Jane Street
New York
|
-$12.3K |